George Quesnelle, president of GlaxoSmithKline Consumer Healthcare, echoed the CHPA position. GSK makes and markets Nicorette. Mr. Quesnelle said significantly more people have quit smoking since nicotine replacement products were moved OTC.
This idea was 'precipitated by drug companies' that want to switch statins to OTC status. DR. WOLFE